Study of Kiratadi Kadha (liquid) in the management of acidity.

Randomized controlled clinical study of efficacy of Kiratadi Kwath and Patoladi Kwath in the management of Amlapitta. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085180

Enrollment

Registered

2025-04-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K318- Other specified diseases of stomach and duodenum

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having symptoms of Amlapitta. 2. Patients having duration of symptoms more than 1 month and less than 2 years. 3. Patients having at least the presence of 4-5 symptoms will be selected. 4. Patients between age group 18 to 60 years of either gender.

Exclusion criteria

Exclusion criteria: 1. Patient with known case of gastric ulcer, duodenal ulcer, stomach cancer. 2. Patient suffering from Diabetes mellitus, Hypertension ,Thyroid disorders and any other co morbidity. 3. Long-term addictions like alcoholism, smoking, tobacco chewing, drugs etc. 4. Pregnancy and lactating women.

Design outcomes

Primary

Measure	Time frame
To observe and document the efficacy of Kiratadi Kwath in the management of Amlapitta.Timepoint: Assessment of 0th 7th 14th Day	—

Secondary

Measure	Time frame
To find out adverse effect of Kiratadi Kwath if anyTimepoint: Assessment of 0th 7th 14th Day	—

Countries

India

Contacts

Public ContactVd Sushrut S Sardeshmukh

Bhartiya Sanskriti Darshan Trusts Ayurved Mahavidyalaya

ayuharmony@gmail.com9011074077

Outcome results